Allergy immunotherapy: the future of allergy treatment
| Autor: | Louise Broge, Henrik H. Jacobi, Jørgen Nedergaard Larsen |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty Allergy medicine.medical_treatment Alternative medicine Disease 03 medical and health sciences 0302 clinical medicine Pharmacotherapy Drug Discovery medicine Hypersensitivity Animals Humans Intensive care medicine Asthma Pharmacology business.industry Rhinitis Allergic Seasonal Immunotherapy Allergens medicine.disease Slit 030104 developmental biology 030228 respiratory system Immunology Costs and Cost Analysis Hay fever business |
| Zdroj: | Drug Discovery Today. 21(1):26-37 |
| ISSN: | 1359-6446 |
| DOI: | 10.1016/j.drudis.2015.07.010 |
| Popis: | Allergic respiratory disease represents a significant and expanding health problem worldwide. Allergic symptoms, such as asthma and hay fever, cause sleep impairment and reduce school and work performance. The cost to society is substantial. Allergen avoidance and pharmacotherapy cannot control the disease. Only allergy immunotherapy has disease-modifying potential and should be included in optimal treatment strategies. Allergy immunotherapy was first administered as subcutaneous injections and has been practiced for the past 100 years or so. Recently, tablet-based sublingual allergy immunotherapy (SLIT) was introduced with comprehensive clinical documentation. SLIT tablets represent a more patient-friendly concept because they can be used for self-treatment at home. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect